Kriston Feleccia, 37, who has struggled with addiction most of her life, said her opioid addiction began when she was ...
Novo Nordisk considers exploring GLP-1 drugs like semaglutide for addiction treatment, following Eli Lilly's interest.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback